A 5-year Superion(R) IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

This study, funded by Boston Scientific, is underway to better understand real-world outcomes of the Vertiflex® Procedure in routine clinical practice. The Vertiflex® Procedure uses the Superion® Indirect Decompression System (IDS), a medical device approved for commercial use by the Food and Drug Administration (FDA) in the
United States for treatment of moderate lumbar spinal stenosis.

Primary Investigator: 
Neel Mehta, MD
Status: 
Open to Enrollment
Category: 
Pain Management

Contact Us

Dept. of Anesthesiology
NewYork-Presbyterian Hospital/Weill Cornell Medicine
525 East 68th Street, Box 124
New York, NY 10065

Office of the Chair
Phone: (212) 746-2962
E-mail:  Office of the Chair, anesthesiology-chair@med.cornell.edu

Residency and Fellowship Education
Direct all inquiries to:
Phone: (212) 746-2941
E-mail: anes-programs@med.cornell.edu
For trainee verification inquiries: anes-verification@med.cornell.edu

Patient Billing Inquiries
Phone: (855) 880-0343